《局限期胰腺癌的放化疗进展》为作者：陈力宁最新的研究成果，本论文的主要观点为根据术前肿瘤与相邻血管的关系胰腺癌分为可手术切除、临界可切除和不可手术切除病变。就诊时，大部分患者已为局部晚期或出现远处转移，只有20%的患者有手术机会，放化疗对于胰腺癌至关重要。本文通过回顾近年来的文献着重介绍局限期胰腺癌新辅助放化疗、立体定向放疗及放化疗联合免疫治疗的研究进展。 Pancreatic cancer is technically divided into surgical resectable, borderline resectable or unresectable disease according to the relationship between tumor mass and adjacent blood vessels。 At the time of diagnosis, most of the lesions were locally advanced or had distant metastases，and only 20% of the patients had the opportunity for tumor resection。 Radiotherapy and chemotherapy are essential for pancreatic cancer, this paper reviews the literatures published in recent years to focus on treatment progress of the neoadjuvant radiotherapy and chemotherapy, SBRT and radiotherapy and chemotherapy combined with immunotherapy for locally advanced pancreatic cancer。不知是否符合录用要求，望您批评与指正。